Literature DB >> 30194773

STAT6 and IL-10 are required for the anti-arthritic effects of Schistosoma mansoni via different mechanisms.

Y Osada1, Y Horie1, S Nakae2, K Sudo3, T Kanazawa1.   

Abstract

To investigate possible roles of T helper type 2 (Th2) cytokines in the anti-arthritic effects of a blood fluke, Schistosoma mansoni (Sm), for mouse collagen-induced arthritis (CIA), wild-type (WT), signal transducer and activator of transcription 6 (STAT6) knock-out (KO) and interleukin (IL)-10 KO mice were infected with Sm. Three weeks after infection, the mice were immunized with bovine type II collagen (IIC). Arthritis severity was monitored by scoring, measurement of paw thickness and the presence of ankylosis. Serum anti-IIC IgG levels, splenic cytokine production and cytokine gene expression in the popliteal lymph nodes (PLNs) were measured and compared among WT and gene-KO mice. Consistent with our previous findings, Sm infection reduced the arthritis severity in WT mice. Splenic production of IL-17A and tumor necrosis factor (TNF)-α was reduced by the infection. In contrast, Sm infection markedly exacerbated CIA in STAT6 KO mice. In the KO mice, IL-17A production was increased by the infection. Conversely, Sm infection did not affect the exacerbated arthritis in IL-10 KO mice, although IL-17A production was reduced by the helminth. Our results suggest that signaling via STAT6 (presumably IL-4 and/or IL-13) and IL-10 is required for the suppression of CIA by Sm infection, but through different mechanisms. STAT6 was essential for helminth-induced reduction of IL-17A, whereas regulation of the basal arthritis severity by IL-10 was needed in order for it to be sufficiently suppressed by the helminth.
© 2018 British Society for Immunology.

Entities:  

Keywords:  zzm321990Schistosomazzm321990; IL-10; IL-17; IL-4; STAT6; arthritis; collagen; helminth

Mesh:

Substances:

Year:  2018        PMID: 30194773      PMCID: PMC6300695          DOI: 10.1111/cei.13214

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  68 in total

1.  Schistosoma japonicum cystatin attenuates murine collagen-induced arthritis.

Authors:  Fang Liu; Weisheng Cheng; Faustina Pappoe; Xiaodong Hu; Huiqin Wen; Qingli Luo; Shushu Wang; Fang Deng; Yuanyuan Xie; Yuanhong Xu; Jilong Shen
Journal:  Parasitol Res       Date:  2016-07-08       Impact factor: 2.289

2.  rSj16, a recombinant protein of Schistosoma japonicum-derived molecule, reduces severity of the complete Freund's adjuvant-induced adjuvant arthritis in rats' model.

Authors:  X Sun; Y H Liu; Z Y Lv; L L Yang; S M Hu; H Q Zheng; W Hu; J P Cao; M Q Fung; Z D Wu
Journal:  Parasite Immunol       Date:  2010 Nov-Dec       Impact factor: 2.280

3.  Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain.

Authors:  Y B Guedez; K B Whittington; J L Clayton; L A Joosten; F A van de Loo; W B van den Berg; E F Rosloniec
Journal:  Arthritis Rheum       Date:  2001-10

Review 4.  Asthma and current intestinal parasite infection: systematic review and meta-analysis.

Authors:  Jo Leonardi-Bee; David Pritchard; John Britton
Journal:  Am J Respir Crit Care Med       Date:  2006-06-15       Impact factor: 21.405

5.  Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13.

Authors:  N Bessis; M C Boissier; P Ferrara; T Blankenstein; D Fradelizi; C Fournier
Journal:  Eur J Immunol       Date:  1996-10       Impact factor: 5.532

6.  Toxoplasma gondii infection inhibits Th17-mediated spontaneous development of arthritis in interleukin-1 receptor antagonist-deficient mice.

Authors:  Takuya Washino; Masataka Moroda; Yoichiro Iwakura; Fumie Aosai
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

7.  Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy.

Authors:  R O Williams; L Marinova-Mutafchieva; M Feldmann; R N Maini
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

8.  Essential role of Stat6 in IL-4 signalling.

Authors:  K Takeda; T Tanaka; W Shi; M Matsumoto; M Minami; S Kashiwamura; K Nakanishi; N Yoshida; T Kishimoto; S Akira
Journal:  Nature       Date:  1996-04-18       Impact factor: 49.962

9.  Reciprocal effects of Schistosoma mansoni infection on spontaneous autoimmune arthritis in IL-1 receptor antagonist-deficient mice.

Authors:  Yoshio Osada; Sohsuke Yamada; Susumu Nakae; Katsuko Sudo; Tamotsu Kanazawa
Journal:  Parasitol Int       Date:  2014-09-09       Impact factor: 2.230

10.  Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.

Authors:  Kojiro Sato; Ayako Suematsu; Kazuo Okamoto; Akira Yamaguchi; Yasuyuki Morishita; Yuho Kadono; Sakae Tanaka; Tatsuhiko Kodama; Shizuo Akira; Yoichiro Iwakura; Daniel J Cua; Hiroshi Takayanagi
Journal:  J Exp Med       Date:  2006-11-06       Impact factor: 14.307

View more
  4 in total

Review 1.  The Potential Role of Schistosome-Associated Factors as Therapeutic Modulators of the Immune System.

Authors:  Junhui Li; Hong Liu; Jie Jiang; Xingguo She; Ying Niu; Yingzi Ming
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

2.  Na-AIP-1 secreted by human hookworms suppresses collagen-induced arthritis.

Authors:  Kane Langdon; Geraldine Buitrago; Darren Pickering; Paul Giacomin; Alex Loukas; Nagaraja Haleagrahara
Journal:  Inflammopharmacology       Date:  2022-01-15       Impact factor: 4.473

3.  Roles of TLR7 in Schistosoma japonicum Infection-Induced Hepatic Pathological Changes in C57BL/6 Mice.

Authors:  Yuanfa Feng; Hongyan Xie; Feihu Shi; Dianhui Chen; Anqi Xie; Jiajie Li; Chao Fang; Haixia Wei; He Huang; Xingfei Pan; Xiaoping Tang; Jun Huang
Journal:  Front Cell Infect Microbiol       Date:  2021-10-08       Impact factor: 5.293

Review 4.  Schistosome Infection and Schistosome-Derived Products as Modulators for the Prevention and Alleviation of Immunological Disorders.

Authors:  Yi Mu; Donald P McManus; Nan Hou; Pengfei Cai
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.